Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Cardiac Failure

• Publication date

  2013-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cardfail.2013.01.001PMID 23384633PMCID PMC3566630
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography

  2014cited by this paper
• Multifactorial risk factor intervention in patients with Type 2 diabetes improves arginine bioavailability ratios

  2012cited by this paper
• Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1.

  2012cited by this paper
• Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography.

  2011cited by this paper
• Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure

  2010cited by this paper
• Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats.

  2010cited by this paper
• Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk.

  2009cited by this paper
• CONSTITUTIVE NITRIC OXIDE SYNTHASES IN THE HEART FROM HYPERTROPHY TO FAILURE

  2008cited by this paper
• Effects of carvedilol on right ventricular ejection fraction and cytokines levels in patients with systolic heart failure.

  2008cited by this paper
• Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure.

  2008cited by this paper
• Tissue Doppler Imaging

  2007cited by this paper
• Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species.

  2007cited by this paper
• Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure.

  2007cited by this paper
• Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism.

  2006cited by this paper
• Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

  2005cited by this paper
• Usefulness of tissue doppler and color M-mode indexes of left ventricular diastolic function in predicting outcomes in systolic left ventricular heart failure (from the ADEPT study).

  2005cited by this paper
• PET abnormalities in patients with nonischemic cardiomyopathy.

  2004cited by this paper
• Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function.

  2004cited by this paper
• High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level

  2003cited by this paper
• Reduced Myocardial and Systemic l-Arginine Uptake in Heart Failure

  2002cited by this paper
• Plasma nitric oxide level in heart failure secondary to left ventricular diastolic dysfunction.

  2001cited by this paper
• Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy.

  1998cited by this paper
• Mechanisms of nitrate accumulation in plasma during pacing-induced heart failure in conscious dogs.

  1997cited by this paper
• Expression of inducible nitric oxide synthase in human heart failure.

  1997cited by this paper
• Expression of inducible nitric oxide synthase in human heart failure.

  1996cited by this paper
• Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure.

  1993cited by this paper
• Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma.

  1986cited by this paper

• l-Arginine: A multifaceted regulator of diabetic cardiomyopathy.

  2025cites this paper
• Supplementation of Arginine or N-Carbamylglutamate Affects Jejunum Development, Global Arginine Bioavailability Ratio, and Stress-Related Indices in Young Rex Rabbits

  2025cites this paper
• Advancing approaches to identify young children at risk for post-discharge mortality: Protocol for a prospective observational cohort study in Western Kenya

  2025cites this paper
• Cardiotropic effect of natural nitric oxide donor in doxorubicin cardiomyopathy

  2024cites this paper
• L-arginine and Its Derivatives Correlate with Exercise Capacity in Patients with Advanced Heart Failure

  2023cites this paper
• A Low Arginine/Ornithine Ratio is Associated with Long-Term Cardiovascular Mortality

  2023cites this paper
• Arginine Dysregulation and Myocardial Dysfunction in a Mouse Model and Children with Chronic Kidney Disease

  2023cites this paper
• Homoarginine in the cardiovascular system: Pathophysiology and recent developments

  2022cites this paper
• Implications for the Metabolic Fate of Oral Glutamine Supplementation within Plasma and Erythrocytes of Patients with Sickle Cell Disease: A Pharmacokinetics Study.

  2022cites this paper
• Blood metabolomes as non-invasive biomarkers and targets of metabolic interventions for doxorubicin and trastuzumab-induced cardiotoxicity

  2022cites this paper
• Metabolomic Profiling of Adults with Congenital Heart Disease

  2021cites this paper
• Decreased arginine bioavailability in patients with coronary artery disease in an outpatient setting

  2020cites this paper
• Decreased arginine bioavailability in patients with coronary artery disease in an outpatient setting

  2020cites this paper
• Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review.

  2019cites this paper
• l-arginine alleviates doxorubicin-induced endothelium-dependent dysfunction by promoting nitric oxide generation and inhibiting apoptosis.

  2019cites this paper
• Novel Markers of the Metabolic Impact of Exogenous Retinoic Acid with A Focus on Acylcarnitines and Amino Acids

  2019cites this paper
• Microbiota intestinal na saúde e doença cardiovascular. Revisão do Estado da Arte do JACC

  2019cites this paper
• Arginine deficiency measured by global arginine bioavailability ratio in patients with acute coronary syndrome

  2018cites this paper
• Official Announcement of Physiological Diagnostic Criteria for Vascular Failure from the Japanese Society for Vascular Failure

  2018cites this paper
• Alterations in plasma L-arginine and methylarginines in heart failure and after heart transplantation

  2018cites this paper
• Metabolic Biomarkers in Heart Failure.

  2018cites this paper
• Arginine deficiency measured by global arginine bioavailability ratio in patients with acute coronary syndrome

  2018cites this paper
• Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis

  2018cites this paper
• Pulmonary hypertension related to heart failure and hypoxia. Mechanisms, new treatment strategies and impact on mortality following heart transplantation. Experiences from Skåne University Hospital in Lund

  2018cites this paper
• Acquired Amino Acid Deficiencies: A Focus on Arginine and Glutamine

  2017cites this paper
• Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients.

  2017cites this paper
• Drastic decrease of global l-arginine bioavailability during orthotopic liver transplantation: A matter of ATP deficiency of the graft?

  2017cites this paper
• L-Arginine Modulates Glucose and Lipid Metabolism in Obesity and Diabetes.

  2017cites this paper
• Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.

  2017cites this paper
• Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention

  2017cites this paper
• Effects of l-arginine supplementation associated with continuous or interval aerobic training on chronic heart failure rats.

  2017cites this paper
• A relative L‐arginine deficiency contributes to endothelial dysfunction across the stages of the menopausal transition

  2017cites this paper
• The Defective Arginine-Nitric Oxide Pathway in Sickle Cell Disease

  2017cites this paper
• Relation between change in exercise capacity and change in blood amino acids in patients with chronic heart failure

  2017cites this paper
• Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation.

  2016influential citation
• Strategies to increase nitric oxide signalling in cardiovascular disease

  2015cites this paper
• Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia

  2015cites this paper
• Arginase inhibition augments nitric oxide production and facilitates left ventricular systolic function in doxorubicin‐induced cardiomyopathy in mice

  2014cites this paper
• Alterations of the arginine metabolome in sickle cell disease: a growing rationale for arginine therapy.

  2014cites this paper
• Novel metabolic roles of L-arginine in body energy metabolism and possible clinical applications

  2014cites this paper